SPIRIVA HANDIHALER 18 MCG CAP

TIOTROPIUM BROMIDE
$10.6228per EA

Strength

18 ug/1

NDC

00597007541

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL; RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021395

On Market Since

10/11/2005

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price History

1W

0.0%

1M

-0.0%

3M

+0.0%

6M

+0.0%

1Y

-0.1%

3Y

-35.2%

5Y

-30.5%

All

+17.1%